Cell-Based Assays for Immuno-Oncology | The Scientist Magazine®

Immunotherapies are paradigm-shifting treatment approaches that have forever changed oncology research and drug development. With increasingly complex and specific immuno-oncology treatment modalities, assays that measure drug immunogenicity and immunotoxicity are critical for researchers seeking deeper insights into the immune system, tumor immune escape, and therapy efficacy.

Download this ebook from Lonza to learn about

• Types of cellular assays for safe and effective drug discovery
• How to use primary cells for measuring immunogenicity and immunotoxicity
• Key considerations for the use of donor diversity and HLA-typing in drug testing
• Cellular application trends in immuno-oncology